Abbott (NYSE: ABT) reported Q3 EPS of $0.54, $0.01 better than the analyst estimate of $0.53. Revenue for the quarter came in at $5.15 billion versus the consensus estimate of $5.15 billion.

Abbott narrowed its full-year 2015 adjusted EPS guidance range for continuing operations to $2.14 to $2.16. Projected full-year 2015 EPS for continuing operations under GAAP is $1.59 to $1.61.

*** The Street sees FY15 EPS of $2.16. Abbot previously guided for FY15 EPS of $2.10 to $2.20.

For earnings history and earnings-related data on Abbott (ABT) click here.